Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NDAC Input Sought On Sunscreen Ingredient Data Necessary For Approval

This article was originally published in The Tan Sheet

Executive Summary

FDA’s Nonprescription Drugs Advisory Committee will meet Sept. 4-5 to discuss the scope and safety of testing necessary for OTC sunscreen ingredients. The announcement comes after FDA earlier this year rejected time and extent applications to add new sunscreen actives to the OTC monograph.

Advertisement

Related Content

All OTC Ingredient TEAs Get Review Deadlines In Senate Draft Bill
All OTC Ingredient TEAs Get Review Deadlines In Senate Draft Bill
All OTC Ingredient TEAs Get Review Deadlines In Senate Draft Bill
All OTC Ingredient TEAs Get Review Deadlines In Senate Draft Bill
All OTC Ingredient TEAs Get Review Deadlines In Senate Draft Bill
Without User Fees, OTC Monograph Changes Are Low Priority At FDA
Without User Fees, OTC Monograph Changes Are Low Priority At FDA
FDA Faults BASF Sunscreen Ingredient Data In Latest TEA Rejection
FDA Questions Spray Sunscreen Safety, Efficacy And Monograph Status
MHRA on herbals

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS107067

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel